Showing results (81-90 of 181) with videos related to

Sort By:
Pageof 19
American Journal of Physiology. Renal Physiology|February 28, 2014
Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium dietKevin K Frick, John R Asplin, Christopher D Culbertson, et al.
JBMR Plus|April 8, 2020
Increased Osteoclast and Decreased Osteoblast Activity Causes Reduced Bone Mineral Density and Quality in Genetic Hypercalciuric Stone-Forming RatsNancy S Krieger, Luojing Chen, Jennifer Becker, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 11, 2008
Sensitivity and specificity of 24-hour urine chemistry levels for detecting elevated calcium oxalate and calcium phosphate supersaturationM Adrian Rossi, Eric A Singer, Dragan J Golijanin, et al.
Blood|August 20, 2013
Ovariectomy expands murine short-term hemopoietic stem cell function through T cell expressed CD40L and Wnt10BJau-Yi Li, Jonathan Adams, Laura M Calvi, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 25, 2017
An in silico method to predict net calcium transfer during hemodialysisVaibhav Maheshwari, Alhaji Cherif, Doris Fuertinger, et al.
American Journal of Physiology. Renal Physiology|August 9, 2013
1,25(OH)₂D₃-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium dietKevin K Frick, John R Asplin, Nancy S Krieger, et al.
Elife|August 9, 2022
Modeling osteoporosis to design and optimize pharmacological therapies comprising multiple drug typesDavid J Jörg, Doris H Fuertinger, Alhaji Cherif, et al.
Lancet (London, England)|June 29, 2019
Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extensionDonald E Wesson, Vandana Mathur, Navdeep Tangri, et al.
Lancet (London, England)|March 13, 2019
Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trialDonald E Wesson, Vandana Mathur, Navdeep Tangri, et al.
Blood|September 30, 2011
Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemiaBenjamin J Frisch, John M Ashton, Lianping Xing, et al.
Pageof 19